Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients.
Takata K, Stathopoulos P, Cao M, Mané-Damas M, Fichtner ML, Benotti ES, Jacobson L, Waters P, Irani SR, Martinez-Martinez P, Beeson D, Losen M, Vincent A, Nowak RJ, O'Connor KC.
Takata K, et al. Among authors: vincent a.
JCI Insight. 2019 Jun 20;4(12):e127167. doi: 10.1172/jci.insight.127167. eCollection 2019 Jun 20.
JCI Insight. 2019.
PMID: 31217355
Free PMC article.